Advanced Enzyme slips 10% on weak December quarter results

The stock slipped 11% to Rs 1,601 on the BSE

Brokers trade at their computer terminals at a stock brokerage firm in Mumbai. Photo: Reuters
Brokers trade at their computer terminals at a stock brokerage firm in Mumbai. Photo: Reuters
SI Reporter Mumbai
Last Updated : Feb 14 2017 | 2:47 PM IST
Advanced Enzyme Technologies tanked 11% to Rs 1,601 on the BSE after the company reported 27.8% year on year (YoY) decline in its consolidated net profit at Rs 14.38 crore for the quarter ended December 2016 (Q3FY17), due to lower operational income.

The company engaged in manufacturing and sales of enzymes business had profit of Rs 19.91 crore in the year ago quarter.

Net sales of the company during quarter under review was down 18.9% YoY at Rs 60 crore against Rs 74.4 crore in the corresponding quarter of previous fiscal.

Meanwhile, the board has approved the sub-division of face value of share capital of the company from existing Rs 10 per share to Rs 2 per share.

At 02:35 pm; the stock was down 8% at Rs 1,658 on the BSE as compared to 0.06% decline in the S&P BSE Sensex. The trading volumes on the counter jumped multiple folds with a combined 753,363 shares changed hands on the BSE and NSE so far.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Next Story